Overview

Whether Dexmedetomidine Can Improve the Prognosis of Elderly Patients With Postoperative Cognitive Dysfunction

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether postoperative analgesia pump continuous infusion of dexmedetomidine are effective in the prevention of Postoperative delirium and Postoperative cognitive dysfunction.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Zhejiang Cancer Hospital
Treatments:
Dexmedetomidine
Dsuvia
Sufentanil
Criteria
Inclusion Criteria:

- Patients' age ≥65 years

- Underwent elective non-cardiac surgery under general anesthesia

Exclusion Criteria:

- Patients with severe bradycardia (heart rate<55bpm)

- Severe arrhythmia or cardiac dysfunction (ejection fraction<35%)

- Mini-Mental Scale Test (MMSE) Exclusion criteria: illiteracy <18, primary school <21,
junior school and above <25

- Preoperative clear systems and spiritual history of neurological disease or long-term
use of sedatives or antidepressants

- History of alcohol abuse or a history of drug dependence

- Have brain surgery or trauma

- Severe vision or hearing impairment

- Cannot with the completion of tests of cognitive function

- Refused to participate in the study